Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis

BMC Veterinary Research

Volumn 9, Issue , 2013, Pages

  Dip, Ramiro ^a,b   Carmichael, James ^c   Letellier, Ingrid ^d   Strehlau, Guenther ^a   Roberts, Elizabeth ^c   Bensignor, Emmanuel ^e   Rosenkrantz, Wayne ^f  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Novaitis Animal Health US Inc   (United States)

^d Novartis Animal Health SAS   (France)

^e Veterinary Dermatology Referral Service   (France)

^f Animal Dermatology Clinic   (United States)

Author keywords

Atopic dermatitis; Atopica; Ciclosporine; Clinical safety; Cyclosporine; Prednisolone; Pruritus

Indexed keywords

CANIS FAMILIARIS;

ANTIINFLAMMATORY AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; MALE; MULTICENTER STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; PREDNISOLONE; PRURITUS;

EID: 84883868258     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-9-173     Document Type: Article

References (17)

1. Olivry T, DeBoer DJ, Griffin CE, Halliwell REW, Hill PB, Hillier A, et al. The ACVD task force on canine atopic dermatitis: forewords and lexicon. Vet Immunol Immunopathol 2001, 81:143-146. 10.1016/S0165-2427(01)00343-9, 11553374.
2. Halliwell R. Revised nomenclature for veterinary allergy. Vet Immunol Immunopathol 2006, 114:207-208. 10.1016/j.vetimm.2006.08.013, 17005257.
3. Linek M, Favrot C. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners. Vet Dermatol 2010, 21:456-462. 10.1111/j.1365-3164.2010.00899.x, 20492625.
4. Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol 2010, 21:233-248. 10.1111/j.1365-3164.2010.00889.x, 20456716.
5. Steffan J, Alexander D, Brovedani F, Fisch RD. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Vet Dermatol 2003, 14:11-22. 10.1046/j.1365-3164.2003.00318.x, 12603681.
6. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol 2006, 17:3-16. 10.1111/j.1365-3164.2005.00491.x, 16412115.
7. Ferrer L, Alberola J, Queralt M, Brazis P, Rabanal R, Llenas J, et al. Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet Rec 1999, 145:191-194. 10.1136/vr.145.7.191, 10501583.
8. Olivry T, Foster AP, Mueller RS, McEwan NA, Chesney C, Williams HC. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 2010, 21:4-22. 10.1111/j.1365-3164.2009.00784.x, 20187910.
9. Whitley NT, Day MJ. Immunomodulatory drugs and their application to the management of canine immune-mediated disease. J Small Anim Pract 2011, 52:70-85. 10.1111/j.1748-5827.2011.01024.x, 21265846.
10. Miller WH, Griffin CE, Campbell KL, Muller GH, Scott DW. Muller & Kirk's small animal dermatology 2013, St. Louis, Mo: Elsevier/Saunders, 7.
11. Font A, Bardagi M, Mascort J, Fondevila D. Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie. Vet Dermatol 2006, 17:440-442. 10.1111/j.1365-3164.2006.00552.x, 17083576.
12. Favrot C, Steffan J, Seewald W, Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010, 21:23-31. 10.1111/j.1365-3164.2009.00758.x, 20187911.
13. Olivry T, Marsella R, Iwasaki T, Mueller R. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007, 18:78-86. 10.1111/j.1365-3164.2007.00569.x, 17355421.
14. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) expert group VICH Topic GL9 (GCP) Guideline on Good Clinical Practices. 2000, London, UK: The European Agency for the Evaluation of Medicinal Products, International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) expert group.
15. Palmeiro BS. Cyclosporine in Veterinary Dermatology. Vet Clin North Am Small Anim Pract 2013, 43:153-171. 10.1016/j.cvsm.2012.09.007, 23182330.
16. Steffan J, Parks C, Seewald W. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. J Am Vet Med Assoc 2005, 226:1855-1863. 10.2460/javma.2005.226.1855, 15934253.
17. Ferguson DC, Dirikolu L, Hoenig M. Glucocorticoids, Mineralocorticoids, and Adrenolytic Drugs. Veterinary pharmacology and therapeutics (HR Adams, ed) 2009, 771-802. Ames, Iowa: Wiley-Blackwell, Riviere JE, Papich MG, 9.